Jožef Stefan Institute, Department of Environmental Sciences, Ljubljana, Slovenia.
Ultrason Sonochem. 2013 Jul;20(4):1104-12. doi: 10.1016/j.ultsonch.2012.12.003. Epub 2012 Dec 28.
To augment the removal of pharmaceuticals different conventional and alternative wastewater treatment processes and their combinations were investigated. We tested the efficiency of (1) two distinct laboratory scale biological processes: suspended activated sludge and attached-growth biomass, (2) a combined hydrodynamic cavitation-hydrogen peroxide process and (3) UV treatment. Five pharmaceuticals were chosen including ibuprofen, naproxen, ketoprofen, carbamazepine and diclofenac, and an active metabolite of the lipid regulating agent clofibric acid. Biological treatment efficiency was evaluated using lab-scale suspended activated sludge and moving bed biofilm flow-through reactors, which were operated under identical conditions in respect to hydraulic retention time, working volume, concentration of added pharmaceuticals and synthetic wastewater composition. The suspended activated sludge process showed poor and inconsistent removal of clofibric acid, carbamazepine and diclofenac, while ibuprofen, naproxen and ketoprofen yielded over 74% removal. Moving bed biofilm reactors were filled with two different types of carriers i.e. Kaldnes K1 and Mutag BioChip™ and resulted in higher removal efficiencies for ibuprofen and diclofenac. Augmentation and consistency in the removal of diclofenac were observed in reactors using Mutag BioChip™ carriers (85%±10%) compared to reactors using Kaldnes carriers and suspended activated sludge (74%±22% and 48%±19%, respectively). To enhance the removal of pharmaceuticals hydrodynamic cavitation with hydrogen peroxide process was evaluated and optimal conditions for removal were established regarding the duration of cavitation, amount of added hydrogen peroxide and initial pressure, all of which influence the efficiency of the process. Optimal parameters resulted in removal efficiencies between 3-70%. Coupling the attached-growth biomass biological treatment, hydrodynamic cavitation/hydrogen peroxide process and UV treatment resulted in removal efficiencies of >90% for clofibric acid and >98% for carbamazepine and diclofenac, while the remaining compounds were reduced to levels below the LOD. For ibuprofen, naproxen, ketoprofen and diclofenac the highest contribution to overall removal was attributed to biological treatment, for clofibric acid UV treatment was the most efficient, while for carbamazepine hydrodynamic cavitation/hydrogen peroxide process and UV treatment were equally efficient.
为了增强药物的去除效果,研究了不同的传统和替代废水处理工艺及其组合。我们测试了以下几种方法的效率:(1)两种不同的实验室规模生物处理工艺:悬浮活性污泥和附着生长生物膜;(2)结合水力空化-过氧化氢工艺;(3)UV 处理。选择了 5 种药物,包括布洛芬、萘普生、酮洛芬、卡马西平和双氯芬酸,以及脂质调节剂氯贝酸的一种活性代谢物。使用实验室规模的悬浮活性污泥和移动床生物膜流动通过反应器评估生物处理效率,这些反应器在水力停留时间、工作体积、添加药物浓度和合成废水组成方面的条件相同。悬浮活性污泥工艺对氯贝酸、卡马西平和双氯芬酸的去除效果较差且不一致,而布洛芬、萘普生和酮洛芬的去除率超过 74%。移动床生物膜反应器中填充了两种不同类型的载体,即 Kaldnes K1 和 Mutag BioChip™,这两种载体对布洛芬和双氯芬酸的去除效率更高。与使用 Kaldnes 载体和悬浮活性污泥的反应器相比,使用 Mutag BioChip™载体的反应器中双氯芬酸的去除效果得到了增强和一致性(85%±10% 比 74%±22% 和 48%±19%)。为了增强药物的去除效果,评估了水力空化-过氧化氢工艺,并确定了去除效率与空化持续时间、添加过氧化氢量和初始压力等因素之间的最佳关系,这些因素都影响着工艺的效率。最佳参数导致去除效率在 3-70%之间。将附着生长生物膜生物处理、水力空化-过氧化氢工艺和 UV 处理相结合,可使氯贝酸的去除效率达到>90%,卡马西平和双氯芬酸的去除效率达到>98%,而其余化合物的浓度则降至低于检测限以下。对于布洛芬、萘普生、酮洛芬和双氯芬酸,生物处理对总去除效果的贡献最大,对于氯贝酸,UV 处理的效率最高,而对于卡马西平,水力空化-过氧化氢工艺和 UV 处理的效率相同。